# US 2023/0056646 A1 · Recombinant proteins having enzyme activity against microcystin and methods of water remediation

> Agents: this data is available as JSON from the patentgrep API and MCP server — see https://patentgrep.com/llms.txt

- Number: US 2023/0056646 A1
- Document ID: US20230056646A1
- Status: Published application
- Kind: A1
- Application number: 17/405,012
- Filed: 2021-08-17
- Published: 2023-02-23
- Earliest claimed: 2021-08-17
- Assignees: The United States of America as represented by the Secretary of the Army
- Applicants: United States of America as Represented by The Secretary of The Army
- Inventors: Carina M Jung; Karl J Indest; Matthew R Carr; Nathan E Harms
- Web page: https://patentgrep.com/patent/US20230056646A1

## CPC

- C12N 9/48: acting on peptide bonds (3.4)
- C02F 3/06: using submerged filters
- C02F 3/341: {Consortia of bacteria}
- C02F 3/342: {characterised by the enzymes used}
- C02F 2101/305: {Endocrine disruptive agents}
- C02F 2101/34: containing oxygen
- C02F 2101/38: containing nitrogen
- C02F 2103/007: {Contaminated open waterways, rivers, lakes or ponds}
- C12N: MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA (microbiological testing media C12Q1/00)
- C02F: TREATMENT OF WATER, WASTE WATER, SEWAGE, OR SLUDGE (separation in general B01D; special arrangements on waterborne vessels of installations for treating water, waste water or sewage, e.g. for producing fresh water, B63J; adding materials to water to prevent corrosion C23F; treating radioactively-contaminated liquids G21F9/04; regeneration of reactants for recirculation into processes, see the relevant places for the processes)

## Abstract

Recombinant MlrA and MlrB proteins having enzymatic activity against microcystin (MC) degrade and reduce the toxicity of MC. Compositions of the proteins can be used in the remediation of MC toxin generated from harmful cyanobacterial and algal blooms. Recombinant proteins, nucleic acids, host cells, and methods of producing the MlrA and MlrB are disclosed.

## Claims

### Claim 1

A combination of recombinant proteins, the combination comprising MlrA and MlrB, the combination of recombinant proteins having enzymatic activity against microcystin.

### Claim 2 (depends on 1)

The combination of recombinant proteins according to claim 1, wherein at least one of the MlrA and MlrB is from a microorganism selected from the group consisting of: Sphingopyxis, Sphingomona, Novosphingobium, Sphingosinicella, Stenotrophomonas, Catellibacterium, Kurthia, Rhizobium, Phyllobacterium, Actinoplanes, Pseudoxanthomonas, and Bacillus.

### Claim 3 (depends on 1)

The combination of recombinant proteins according to claim 1, wherein at least one of the MlrA and MlrB is from Sphingopyxis sp. C-1.

### Claim 4 (depends on 1)

The combination of recombinant proteins according to claim 1, wherein:
the MlrA protein has the amino acid sequence of SEQ ID NO: 5, or has at least 70% identity to the amino acid sequence of SEQ ID NO: 5 and has enzymatic activity against cyclic microcystin; and
the MlrB protein has the amino acid sequence of SEQ ID NO: 6, or has at least 70% identity to the amino acid sequence of SEQ ID NO: 6 and has enzymatic activity against linearized microcystin.

### Claim 5 (depends on 1)

The combination of recombinant proteins according to claim 1, wherein the microcystin is selected from the group consisting of Microcystin-LR, Microcystin-RR, Microcystin-YR, Microcystin-LA, Microcystin-LY, Microcystin-LW, and Microcystin-LF.

### Claim 6 (depends on 1)

The combination of recombinant proteins according to claim 1, wherein the enzymatic activity is microcystinase and linearized microcystinase.

### Claim 7 (depends on 1)

A composition comprising the combination of recombinant proteins according to claim 1, the composition having enzymatic activity against microcystin.

### Claim 8

A recombinant nucleic acid encoding recombinant MlrA protein and MlrB protein, the recombinant MlrA protein and MlrB protein having enzymatic activity against microcystin.

### Claim 9 (depends on 8)

The recombinant nucleic acid according to claim 8, wherein:
the nucleic acid encodes for MlrA protein having the amino acid sequence of SEQ ID NO: 5, or having at least 70% identity to the amino acid sequence of SEQ ID NO: 5 and having enzymatic activity against cyclic microcystin; and
the nucleic acid encodes for MlrB having the amino acid sequence of SEQ ID NO: 6, or having at least 70% identity to the amino acid sequence of SEQ ID NO: 6 and having enzymatic activity against linearized microcystin.

### Claim 10 (depends on 8)

The recombinant nucleic acid according to claim 8, comprising a first gene encoding the recombinant MlrA protein and a second gene encoding the recombinant MlrB protein, wherein the first and second genes have a bicistronic arrangement in the nucleic acid.

### Claim 11

A method of degrading microcystin, the method comprising contacting the microcystin with a combination of recombinant MlrA and MlrB proteins, the combination of recombinant MlrA and MlrB proteins having enzymatic activity against microcystin.

### Claim 12

A method of reducing the level of microcystin in MC-containing water, the method comprising bringing the water into contact with a combination of recombinant MlrA and MlrB proteins, the combination of recombinant MlrA and MlrB proteins having enzymatic activity against microcystin.

### Claim 13 (depends on 12)

The method according to claim 12, wherein the microcystin is contained in water contaminated by a harmful cyanobacterial/algal bloom.

### Claim 14 (depends on 12)

The method according to claim 12, wherein the MC-containing water is lake water, reservoir water, pond water, river water, irrigation water, or a source of drinking water.

### Claim 15

A recombinant cell, comprising a heterologous gene encoding recombinant MlrA and MlrB proteins, the recombinant MlrA and MlrB proteins having enzymatic activity against microcystin.

### Claim 16 (depends on 15)

The recombinant cell according to claim 15, wherein the heterologous gene comprises coding sequences for MlrA and MlrB in a bicistronic arrangement.

### Claim 17 (depends on 15)

A method of producing recombinant MlrA and MlrB proteins having enzymatic activity against microcystin, comprising culturing the recombinant cell according to claim 15 in a culture medium.

### Claim 18 (depends on 15)

The method according to claim 15, wherein the heterologous gene has been codon optimized for expression of the recombinant MlrA and MlrB proteins in the recombinant cell.
